Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Meridian Bioscience (NQ: VIVO )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Meridian Bioscience

< Previous 1 2 3 4 Next >
DoubleVerify To Join S&P SmallCap 600 On January 31
Via Benzinga
Meridian Bioscience's Return On Capital Employed Overview
Via Benzinga
Cannabis Stock Gainers And Losers From December 12, 2022
Via Benzinga
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
This quartet of stocks has plenty of growth ahead and is already profitable. 
Via The Motley Fool
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level. 
Via Investor's Business Daily
Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark
Penumbra stock cleared a key 80-plus relative strength benchmark Monday, with a jump to 87 from 79 on Friday. 
Via Investor's Business Daily
Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much
Via Benzinga
Looking Into Meridian Bioscience's Return On Capital Employed
Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 125.52%, resulting in a loss of $7.34... 
Via Benzinga
Meridian Bioscience: Q3 Earnings Insights
  Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
Preview: Meridian Bioscience's Earnings
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Meridian... 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022
Via Benzinga
MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO
From Kahn Swick & Foti, LLC
Via Business Wire
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
AMC Entertainment (AMC) stock is in the news today as investors in the theater company prepare for a potential catalyst coming next month! 
Via InvestorPlace
Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement
VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news. 
Via InvestorPlace
VIVO Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Meridian Bioscience, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
Cannabis Stock Gainers And Losers From July 6, 2022
GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50 
Via Benzinga
Marijuana Stock Movers For June 30, 2022
GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 6.42% at $1.16 
Via Benzinga
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform
Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors. 
Via Benzinga
Cannabis Stock Movers For June 29, 2022
GAINERS: Cansortium (OTC:CNTMF) shares closed up 4.07% at $0.17 
Via Benzinga
Cannabis Stock Movers For June 28, 2022
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 16.35% at $0.79 
Via Benzinga
Cannabis Stock Gainers And Losers From June 27, 2022
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 46.08% at $0.02 
Via Benzinga
Cannabis Stock Gainers And Losers From June 17, 2022
GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 10.10% at $7.63 
Via Benzinga
Cannabis Stock Movers For June 9, 2022
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 35.09% at $1.29 LOSERS: 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 8, 2022
GAINERS: Cansortium (OTC:CNTMF) shares closed up 12.00% at $0.22 
Via Benzinga
Cannabis Stock Movers For June 6, 2022
GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 17.12% at $0.87 
Via Benzinga
Looking Into Meridian Bioscience's Return On Capital Employed
According to Benzinga Pro, during Q2, Meridian Bioscience (NASDAQ:VIVO) earned $28.75 million, a 87.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $111.23 million... 
Via Benzinga
This Company Looks To Make Its Value-Added Technologies Benefit Smartphone Consumers In China — Then The World?
Photo by Deep Advani on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.